n/a
Abstract Title:

The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.

Abstract Source:

Arch Gynecol Obstet. 2011 Jun ;283(6):1319-23. Epub 2010 Jun 25. PMID: 20577750

Abstract Author(s):

Maria Le Donne, Carmela Caruso, Alfredo Mancuso, Gregorio Costa, Raffaella Iemmo, Giovanni Pizzimenti, Vittorio Cavallari

Article Affiliation:

Maria Le Donne

Abstract:

PURPOSE: The quality of life in postmenopause is seriously affected by the symptoms related to vaginal atrophy. To evaluate in a 3-month, prospective, randomized, double blind, study whether vaginal suppositories containing genistein might improve genital symptoms, colposcopical and cytologic findings or modify DNA cytometric features in postmenopausal women affected by vaginal atrophy, in comparison with vaginal suppositories containing hyaluronic acid (HA).

METHODS: A total of 62 postmenopausal women were randomly assigned to receive intravaginally 97μg of genistein (group A, n = 31) or 5 mg of HA (group B, n = 31) daily for 15 days continuously/month for 3 months. Vaginal and cervical smear, colposcopy, vaginal biopsy were performed before and at the end of the study. Maturation value (MV) was calculated. Flow cytometric analysis of DNA ploidy (DI) and S-phase fraction (SPF) were performed.

RESULTS: After 90 days of study, a significant improvement was obtained in genital symptoms, colposcopy scores and MV (p<0.001) in both groups; the improvement obtained by genistein was more effective especially regarding genital score (p value between groups 0.001). No significant change was found in SPF value and DI.

CONCLUSION: Both treatments improved genital symptoms, colposcopical features and MV, although genistein was more effective on genital score. Both treatments did not significantly influence flow cytometry parameters, although genistein showed slight decrease in DI, with a normalization of the aneuploid content present in some cases that could represent an additional application of intravaginal phytoestrogen therapy, providing an alternative therapy of vaginal atrophy in postmenopausal patients. The results of this investigation should be considered preliminary and need to be verified in larger, prospective studies.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.